The Antitumor Potential of Sicilian Grape Pomace Extract: A Balance between ROS-Mediated Autophagy and Apoptosis
Authors:
- Federica AffranchiFederica Affranchi
- Diana Di LibertoDiana Di Liberto
- Marianna LauricellaMarianna Lauricella
- Antonella D’anneoAntonella D’anneo
- Giuseppe CalvarusoGCGiuseppe Calvaruso
- Giovanni PratelliGiovanni Pratelli
- Daniela CarlisiDCDaniela Carlisi
- Anna De BlasioABAnna De Blasio
- Luisa TesoriereLuisa Tesoriere
- Michela GiulianoMGMichela Giuliano
- Antonietta NotaroAntonietta Notaro
- Sonia EmanueleSonia Emanuele
Open Access
- 3 September 2024
- journal article
- research article
- Published by MDPI AG in Biomolecules
- Vol. 14 (9) , 1111
Abstract
From the perspective of circular economy, it is extremely useful to recycle waste products for human health applications. Among the health-beneficial properties of bioactive phyto-compounds, grape pomace represents a precious source of bioactive molecules with potential antitumor properties. Here, we describe the effects of a Sicilian grape pomace hydroalcoholic extract (HE) in colon and breast cancer cells. The characterization of HE composition revealed the predominance of anthoxanthins and phenolic acids. HE treatment was more effective in reducing the viability of colon cancer cells, while breast cancer cells appeared more resistant. Indeed, while colon cancer cells underwent apoptosis, as shown by DNA fragmentation, caspase-3 activation, and PARP1 degradation, breast cancer cells seemed to not undergo apoptosis. To elucidate the underlying mechanisms, reactive oxygen species (ROS) were evaluated. Interestingly, ROS increased in both cell lines but, while in colon cancer, cells’ ROS rapidly increased and progressively diminished over time, in breast cancer, cells’ ROS increase was persistent up to 24 h. This effect was correlated with the induction of pro-survival autophagy, demonstrated by autophagosomes formation, autophagic markers increase, and protection by the antioxidant NAC. The autophagy inhibitor bafilomycin A1 significantly increased the HE effects in breast cancer cells but not in colon cancer cells. Overall, our data provide evidence that HE efficacy in tumor cells depends on a balance between ROS-mediated autophagy and apoptosis. Therefore, inhibiting pro-survival autophagy may be a tool to target those cells that appear more resistant to the effect of HE.Keywords
Funding Information
- project ProInScar (CUP G11B22000250009)
- University of Palermo (CUP G11B22000250009)
- MATER scarl (CUP G11B22000250009)
This publication has 63 references indexed in Scilit:
- Flavonoids: A treasure house of prospective pharmacological potentialsHeliyon, 2024
- Autophagy: A challengeable paradox in cancer treatmentCancer Medicine, 2023
- Molecular mechanisms behind ROS regulation in cancer: A balancing act between augmented tumorigenesis and cell apoptosisArchives of Toxicology, 2022
- Targeting regulated cell death (RCD) with small-molecule compounds in cancer therapy: A revisited review of apoptosis, autophagy-dependent cell death and necroptosisDrug Discovery Today, 2022
- Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor‐induced senescence in breast cancer cellsCancer Medicine, 2021
- Interactions between reactive oxygen species and autophagyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2021
- Resveratrol induces depletion of TRAF6 and suppresses prostate cancer cell proliferation and migrationThe International Journal of Biochemistry & Cell Biology, 2020
- Antiproliferative and cytotoxic effects of grape pomace and grape seed extracts on colorectal cancer cell linesFood Science & Nutrition, 2019
- Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapyCancer Letters, 2007
- Molecular mechanisms of N -acetylcysteine actionsCellular and Molecular Life Sciences, 2003